Susquehanna International Group’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q2
Sell
-6,944
Closed -$677K 5014
2015
Q1
$677K Sell
6,944
-679
-9% -$66.2K ﹤0.01% 2830
2014
Q4
$707K Sell
7,623
-299
-4% -$27.7K ﹤0.01% 2986
2014
Q3
$544K Sell
7,922
-3,267
-29% -$224K ﹤0.01% 2863
2014
Q2
$1.17M Buy
11,189
+810
+8% +$84.8K ﹤0.01% 2262
2014
Q1
$861K Sell
10,379
-18,964
-65% -$1.57M ﹤0.01% 2213
2013
Q4
$1.9M Buy
29,343
+15,832
+117% +$1.02M ﹤0.01% 1668
2013
Q3
$855K Sell
13,511
-1,814
-12% -$115K ﹤0.01% 2218
2013
Q2
$644K Buy
+15,325
New +$644K ﹤0.01% 2348